Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Amgen
Study ID
NCT03852472
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Avacopan — DRUG
    Active treatment
  • Placebo — OTHER
    Placebo

Study Details

Phase 2 study of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa

Key Dates

Start date
Dec 21, 2018
Status verified
Feb 2025
Primary completion
Jan 14, 2021
Completion
Mar 9, 2021

Study Design

Enrollment
435 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Group A
    Placebo twice daily (BID) for Period 1 of the study
  • Experimental: Group B
    Avacopan 10 mg twice daily (BID) for Period 1+2 of the study
  • Experimental: Group C
    Avacopan 30 mg twice daily (BID) for Period 1+2 of the study
  • Experimental: Placebo to Avacopan 10 mg
    Treatment period 2, subjects randomized to placebo during period 1 were rerandomized 1:1 to receive 10 mg or 30 mg avacopan BID in period 2.
  • Experimental: Placebo to Avacopan 30 mg
    Treatment period 2, subjects randomized to placebo during period 1 were rerandomized 1:1 to receive 10 mg or 30 mg avacopan BID in period 2.

Primary Outcome Measure

Percentage of Subjects Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12. [ Time Frame: Baseline to Week 12 ]

Locations (91)

FacilityCityStateZIPSite coordinators
Clinical SiteBirminghamAlabama35233-
Clinical SiteBirminghamAlabama35244-
Clinical SiteMobileAlabama36608-
Clinical SitePhoenixArizona85006-
Clinical SiteScottsdaleArizona85255-
Clinical SiteFort SmithArkansas72916-
Clinical SiteRogersArkansas72758-
Clinical SiteFountain ValleyCalifornia92708-
Clinical SiteFremontCalifornia94538-
Clinical SiteFullertonCalifornia92821-
Clinical SiteHuntington BeachCalifornia92647-
Clinical SiteInglewoodCalifornia90301-
Clinical SiteLos AngelesCalifornia90025-
Clinical SiteLos AngelesCalifornia90045-
Clinical SiteLos AngelesCalifornia90057-
Clinical SiteManhattan BeachCalifornia90266-
Clinical SiteNewport BeachCalifornia92660-
Clinical SiteNorthridgeCalifornia91324-
Clinical SiteRedwood CityCalifornia94063-
Clinical SiteThousand OaksCalifornia91320-
Clinical SiteWalnut CreekCalifornia94598-
Clinical SiteBoca RatonFlorida33486-
Clinical SiteClearwaterFlorida33765-
Clinical SiteHialeahFlorida33016-
Clinical SiteHollywoodFlorida33021-
Clinical SiteHomesteadFlorida33030-
Clinical SiteMiamiFlorida33125-
Clinical SiteMiamiFlorida33144-
Clinical SiteMiamiFlorida33173-
Clinical SiteOcalaFlorida34470-
Clinical SiteOrlandoFlorida32819-
Clinical SitePembroke PinesFlorida33028-
Clinical SiteTampaFlorida33603-
Clinical SiteTampaFlorida33614-
Clinical SiteTampaFlorida33624-
Clinical SiteWestonFlorida33327-
Clinical SiteAtlantaGeorgia30322-
Clinical SiteMariettaGeorgia30060-
Clinical SiteNewnanGeorgia30263-
Clinical SiteSandy SpringsGeorgia30328-
Clinical SiteBoiseIdaho83713-
Clinical SiteSkokieIllinois60077-
Clinical SiteSkokieIllinois60640-
Clinical SiteCrown PointIndiana46307-
Clinical SiteEvansvilleIndiana47715-
Clinical SiteIndianapolisIndiana46250-
Clinical SiteLouisvilleKentucky40217-
Clinical SiteMetairieLouisiana70006-
Clinical SiteNew OrleansLouisiana70124-
Clinical SiteLargoMaryland20774-
Clinical SiteBeverlyMassachusetts01915-
Clinical SiteBostonMassachusetts02101-
Clinical SiteQuincyMassachusetts94598-
Clinical SiteClarkstonMichigan48346-
Clinical SiteFort GratiotMichigan48059-
Clinical SiteSaint JosephMichigan49085-
Clinical SiteTroyMichigan48084-
Clinical SiteMinneapolisMinnesota55455-
Clinical SiteSt LouisMissouri63110-
Clinical SiteOmahaNebraska68144-
Clinical SiteVeronaNew Jersey07044-
Clinical SiteNew YorkNew York10012-
Clinical SiteRochesterNew York14623-
Clinical SiteChapel HillNorth Carolina27516-
Clinical SiteCharlotteNorth Carolina028277-
Clinical SiteCharlotteNorth Carolina28209-
Clinical SiteCharlotteNorth Carolina28277-
Clinical SiteWilmingtonNorth Carolina28401-
Clinical SiteAthensOhio45701-
Clinical SiteBexleyOhio43209-
Clinical SiteClevelandOhio44106-
Clinical SiteMarionOhio43302-
Clinical SiteMasonOhio45040-
Clinical SiteNormanOklahoma73071-
Clinical SitePortlandOregon97210-
Clinical SiteDrexel HillPennsylvania19026-
Clinical SiteHersheyPennsylvania17033-
Clinical SitePhiladelphiaPennsylvania19104-
Clinical SiteWarwickRhode Island02886-
Clinical SiteCharlestonSouth Carolina29407-
Clinical SiteNashvilleTennessee37215-
Clinical SiteAustinTexas78660-
Clinical SiteAustinTexas78745-
Clinical SiteDallasTexas75231-
Clinical SiteHoustonTexas77054-
Clinical SiteHoustonTexas77056-
Clinical SiteHoustonTexas77084-
Clinical SiteSan AntonioTexas78218-
Clinical SiteSugar LandTexas77027-
Clinical SiteSpokaneWashington99202-
Clinical SiteMorgantownWest Virginia26505-

Find similar trials in Birmingham, AL

Related Studies